Case Report
Giant Condyloma Acuminata in Indonesian Females with SLE under Immunosuppressant and Steroid Therapy
Table 2
Characteristic of each patient in both studies.
| Variable | Lube et al. [9] | Costapinto et al. [10] | 1 | 2 | 3 | 4 | 1 |
| Demographic data | | | | | | Age at SLE diagnosis, years | 12 | 8 | 14 | 15 | 33 | Gender | ♀ | ♀ | ♀ | ♀ | ♀ | SLE therapy | Chloroquine 5 mg/kg/day; prednisone 60 mg/day | Prednisone 2 mg/kg/day; chloroquine 250 mg/day; IV cyclophosphamide 500–1000 mg/m2 | Methylprednisolone 1 g/day; IV cyclophosphamide 750 mg/m2; hydroxychloroquine 300 mg/day; prednisone 2 mg/kg/day | Prednisone 21 mg/kg/day; chloroquine 250 mg/day | Mycophenolate mofetil 2 g/day | Sexual activity | Active | Active | Not active | Active | Active | Period between SLE and GCA, months | 22 | 108 | 1 | 48 | 12 | Clinical features at GCA | Vulva | Vulva, vagina, anal | Vulva and anal | Vulva | Vulva, vagina, perineum, and anal | HPV type | HPV DNA of oncogenic group and cervix biopsy | HPV 16, HPV DNA of oncogenic group and cervix biopsy | HPV DNA of oncogenic group and HPV 16 | HPV DNA of oncogenic group | HPV 6, 11, and 42 |
| Treatments at GCA | | | | | | SLE therapy | Prednisone 20 mg/day; azathioprine 150 mg/day; chloroquine 250 mg/day | Prednisone 20 mg/day; chloroquine 250 mg/day; azathioprine 150 mg/day | Intravenous cyclophosphamide 750 mg/m2; hydroxychloroquine 300 mg/day; prednisone 2 mg/kg/day | Prednisone 5 mg/day; chloroquine 250 mg/day | Mycophenolate mofetil 2 g/day | HPV | LEEP | CO2 laser vaporization | Surgical removal | LEEP | Trichloroacetic acid; TLR7 agonist imiquimod 5% cream; podophyllin 2% oil; operation | Recurrence of GCA | Yes | — | — | — | — |
|
|
♀: female; GCA: giant condyloma acuminata; SLE: systemic lupus erythematosus; LEEP: loop electrosurgical excisional procedure.
|